A simple hydrothermal route for the preparation of novel Na–Y–W nano-oxides and their application in dye degradation

The fabricated NaY(WO₄)₂ was identified through diverse analysis methods. Therefore, to optimize NaY(WO₄)₂ morphology, saccharide carbohydrates were manipulated as a capping agent. In this study, glucose, fructose, lactose, cellulose, and starch were utilized as the capping agents. SEM images show that fructose was the optimal capping agent for achieving uniform and well-shaped nanoparticles. The photodegradation of organic dyes such as M.O and Rd.B by NaY(WO₄)₂ was evaluated under UV and Vis light. The bandgap energy of the as-prepared sample was measured by the Tauc plot, and was found to be nearly 3.85 eV. To study the photocatalytic characteristics, the influence of dye dosage and reusability on photodegradation behavior were investigated.

NaY(WO₄)₂ nanoparticles were fabricated via a simple hydrothermal method using saccharide carbohydrates as capping agents. The photocatalytic behavior of the as-prepared NaY(WO₄)₂ nanostructures was studied.     

Salivary characteristics of children and its relation to oral microorganism and lip mucosa dryness

The aim of this paper was to present baseline data on various saliva properties among a group of Saudi children aged 5 to 11 years and to study the relationship of these properties to some oral micro-organisms as well as to lip and oral mucosa dryness. The results showed a mean of resting and stimulated flow rate of 0.54 +/- 0.40 and 1.23 +/- 0.59 respectively and mean pH value of 7.27 +/- 0.38 and 7.5 +/- .035 respectively. Fluoride concentration was estimated to be 0.151 +/- 0.07 and 0.145 +/- 0.06 in resting and stimulated saliva respectively. Children with dry lip represented 33.9% of the sample population, whereas, those with dry mucosa represented only 0.8%. No significant sex difference was evident in all parameters. 59.1% of children showed medium buffering capacity in the resting saliva, whereas, the majority of children (73.7%) showed high stimulated buffering capacity. Children showed generally high Lactobacillus counts (Lb) in the resting and stimulated saliva (57.9% and 60.5% of children). The presence of yeast also in resting and stimulated saliva seemed high in general (40% and 53% of children had high count). However, Streptococcus mutans (S. mutans) counts showed no discriminating trend in both types of saliva. The data showed no significant association between flow rate and Lb counts in both resting and stimulated saliva although there was a trend toward higher counts associated with low flow rate. The same trend was observed in resting saliva although not significant. Similarly, low resting buffering capacity was associated with high counts of Lb among a high proportion of children (68.6% of children) although not significant. A significant reverse relation was evident between S. mutans counts and stimulated flow rate (p=0.049). The majority of children with normal level of saliva pH showed no yeast colonization (62.1%). The association was significant (p=.024). Similarly, the same association was observed in the medium and high buffering group (66.2%) (p=.040). It was concluded that salivary Lb count seems to be primarily affected by some local factors other than salivary properties, such as diet. Significant inverse relationship was found between S. mutans and stimulated salivary flow. Children in general showed high percentage of yeast reflecting the affect of poor diet among the studied population group. Buffering capacity and pH had an important role in yeast colonization.     

Boceprevir and telaprevir‐based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end‐stage liver disease score

Triple therapy using telaprevir or boceprevir [hepatitis C virus (HCV)‐NS3/NS4A protease inhibitors (PI)] in association with PEG‐IFN/ribavirin has recently become the new standard of care (SOC) for treatment of HCV genotype 1 patients. Our objective was to assess the efficacy and tolerance of triple therapy in routine clinical practice. A total of 186 consecutive HCV patients initiating triple therapy were enrolled in a single centre study. Clinical, biological and virological data were collected at baseline and during follow‐up as well as tolerance and side effect details. Among 186 HCV patients initiating triple therapy, 69% received telaprevir and 31% boceprevir. Sixty‐one per cent of patients had cirrhosis. The overall extended rapid virological response (eRVR) rate and sustained virological response (SVR) rate were 57.0% and 59.7%, respectively. IL28B CC phenotype was associated with increased probability of achieving eRVR and SVR, whereas previous non‐response was associated with low eRVR and SVR rates. The SVR rate increased from 30.8% in previously non‐responders to 59.1% in partial non‐responders and 75% in relapsers. SVR rate in naive patients was 62.5%. Glomerular filtration rate assessed by MDRD after 12 weeks of therapy was significantly reduced for both PI (P < 0.001). The model for end‐stage liver disease (MELD) score was significantly increased at W12 for telaprevir (P = 0.008) and at W24 for boceprevir (P = 0.027). PI‐based triple therapy leads to high rates of virological response even in previously non‐responder patients. Renal function after triple therapy is impaired as well as MELD score in all patients. Cautious clinical monitoring should focus not only on haematological and dermatological side effects but also on renal function.